prostate cancer prostate cancer
Conditions
Interventions
Sponsors
Shoji Sunao
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Patients who have localized prostate cancer with above 20 years old. 2. Patients who were diagnosed the localization of the significant cancer in the prostate. 3. Patients who were informed of this procedure , and underwent this procedure provided informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients who have severe anal strictures. 2. Patients who have prostatic calcification over 10mm in the front of the target lesion. 3. Patients who have the target lesion located out of the treatable area. 4. Patients who were regarded as a inappropriate for the treatment by the responsible doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Oncological outcome, urinary incontinence, erectile dysfunction | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of the blood flow in treated area on dynamic contrast enhanced MRI, Follow-up biopsy in 6 months after the treatment, Serum PSA value in 1, 3, 6, 9, 12, 15, 18, 21, 24 months after the treatment, Urinary function (IPSS, IPSS QOL, OABSS, Uroflowmetry, Residual urine), Sexual function (IIEF-5, FACT-P), Quality of life (SF-36, FACT-G), Complications (Common Terminology Criteria for Adverse Events version 4.0) | — |
Contacts
Public ContactSunao Shoji
Tokai University
Outcome results
None listed